Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
<p><strong>Background</strong></p> <p>Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treatment is mainly with inhalers containing beta₂‐agonists, typically taken as required to relieve bronchospasm, and inhaled corticosteroids (ICS)...
Main Authors: | Crossingham, I, Turner, S, Ramakrishnan, S, Fries, A, Gowell, M, Yasmin, F, Richardson, R, Webb, P, O'Boyle, E, Hinks, TSC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2021
|
Similar Items
-
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
by: Crossingham, I, et al.
Published: (2020) -
Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
by: Crossingham, I, et al.
Published: (2021) -
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
by: Howell, I, et al.
Published: (2023) -
Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
by: Lee SY, et al.
Published: (2016-11-01) -
A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
by: Couillard, S, et al.
Published: (2021)